Mounjaro®
Starting from £179.99/mo
Start journey Learn moreGetting the most from Wegovy comes down to a handful of consistent habits that work alongside the medicine, not instead of it. Semaglutide reduces appetite and slows how quickly the stomach empties, but the people who do best tend to pair that effect with deliberate eating patterns, good hydration, and a clear routine. Wegovy is a prescription-only medicine; a clinician decides whether it is right for you and at what dose, so every tip here sits alongside that clinical relationship, not outside it. The semaglutide treatments page covers the clinical picture in full if you want the background first.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It does, and arguably more than before. The medicine does a great deal of the appetite regulation, but a smaller stomach capacity means every bite carries more weight nutritionally. People on Wegovy who eat mostly ultra-processed food tend to lose less than those who prioritise protein, vegetables, and fibre-rich carbohydrates, even when calorie counts look similar on paper. The reason is partly satiety (protein signals fullness more effectively than refined carbohydrates) and partly muscle. Rapid weight loss without adequate protein causes the body to draw on muscle as well as fat, which slows the metabolism and makes keeping the weight off harder once treatment ends.
The NHS encourages a reduced-calorie diet alongside weight-management medicines, and the practical version of that on Wegovy is not counting every gram but asking: does this meal have a protein anchor, some fibre, and enough slow-release energy to see me through? Aiming for 25–30g of protein at each main meal is a reasonable starting point for most adults, though your prescriber or a dietitian can personalise that. The factors that shape Wegovy weight loss results go into more detail on how diet quality interacts with the treatment's mechanism.
One practical shift: smaller plates genuinely help. Stomach emptying is already slower on semaglutide, so a standard restaurant-sized portion can become genuinely uncomfortable. If you want to see how others have navigated this in practice, you can read wegovy success stories from people who have been through the same adjustments. Eating slowly and stopping before fullness arrives (not at it) is one of the most consistent pieces of advice from people who have done well on treatment.
Semaglutide has a half-life of roughly seven days, which is why it is dosed once weekly rather than daily. That long half-life means a single late injection rarely derails anything, but consistent timing across weeks smooths out peak-and-trough fluctuations in how you feel. Many people find that injecting at the same point in the weekly routine (the pen kept in the fridge door next to the same shelf of food they have every Sunday) makes the habit automatic rather than an effort of memory.
Injection site also matters more than it is sometimes given credit for. Rotating between the abdomen, outer thigh, and upper arm prevents localised skin thickening that can reduce absorption over time. The patient information leaflet supplied with your pen gives the exact technique; reading it once properly is worth the five minutes. If you are unsure about needle change frequency or disposal, our FAQs page covers the practicalities, and sharps containers are available through the pharmacy.
The Wegovy treatment page covers the full titration schedule, the dose increases your prescriber manages over the first months. Each step up is also when GI side effects tend to peak briefly, so timing a dose increase to a slightly quieter week if possible can make the transition more comfortable.
GI symptoms (nausea most commonly, alongside loose stools, indigestion, or feeling uncomfortably full) affect most people at some point on semaglutide, particularly in the first weeks and around dose increases. They are real, they are listed in the prescribing information, and for most people they do settle as the body adjusts. The NHS medicines page for semaglutide gives a plain-English breakdown of what to expect and when to seek help.
Practically, a few adjustments make a consistent difference. Eating slowly and stopping early (before any sensation of fullness rather than at it) reduces the post-meal discomfort that semaglutide can amplify. Avoiding very fatty or very spicy food in the days around an injection helps for some people. Sipping water steadily through the day rather than drinking large quantities at once is kinder to a slower-emptying stomach.
Severe or persistent symptoms are always worth raising with your prescriber rather than pushing through. Severe, persistent stomach pain that radiates to the back should prompt urgent medical attention, the MHRA has issued formal guidance on the association between GLP-1 medicines and acute pancreatitis, and that symptom pattern warrants same-day assessment. Reporting any unexpected side effects through the Yellow Card scheme helps regulators track real-world safety data. If you are on a programme through a registered pharmacy like ours, the aftercare team is there precisely for these conversations, you are not expected to manage them alone.
Quite a lot, based on what clinical programmes consistently show. The STEP 1 trial that underpins Wegovy's licence ran alongside structured lifestyle counselling, and the results (roughly 15% average body weight reduction at 68 weeks) reflect that combination, not the medicine in isolation. Real-world outcomes vary, and people who have access to regular clinical check-ins tend to do better than those managing without any oversight.
What support looks like matters too. A prescriber who reviews your progress before each repeat and adjusts the approach is different from one who simply reissues a prescription. This is one reason to understand what is included before you start treatment anywhere: the how Wegovy is prescribed online page covers what a proper private pathway looks like and what to check for. Our weight-loss treatment overview explains what comes with treatment through nume, priority aftercare seven days a week, and clinical review before every repeat, not just at the start.
Progress also tends to plateau. This is normal physiology, not failure. The body adapts its energy expenditure during sustained weight loss. Continuing resistance activity, keeping protein intake consistent, and flagging the plateau to your prescriber early gives the most options. Sometimes a dose review helps; sometimes a dietary tweak is enough. Reading a wegovy success story from someone who pushed through a plateau can also be a useful reminder that the pattern is common and manageable. The point is that a plateau is information, not a reason to stop.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.